Anti‐inflammatory effect of mesenchymal stem cells on hepatocellular carcinoma in the xenograft mice model

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most diagnosed cancer and the second leading cause of cancer‐related deaths worldwide. Sorafenib is the standard treatment used in the advanced stages of HCC. Cell therapy with mesenchymal stem cells (MSCs)‐based cell therapy has proven effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajighasemlou, Saieh, Nikbakht, Mohsen, Pakzad, Saeedreza, Azadbakht, Abdolnaser, Muhammadnejad, Samad, Mirmoghtadaei, Milad, Gharibzadeh, Safoora, Seyhoun, Iman, Verdi, Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RODENTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514506/
https://www.ncbi.nlm.nih.gov/pubmed/35838746
http://dx.doi.org/10.1002/vms3.886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514506/
https://www.ncbi.nlm.nih.gov/pubmed/35838746
http://dx.doi.org/10.1002/vms3.886

Ejemplares similares